UQ’s vaccine victory
Sanofi’s $1.76 billion acquisition of Vicebio delivers a windfall for the University of Queensland — and highlighted a promising model for commercialising Aussie research.
Sanofi’s $1.76 billion acquisition of Vicebio delivers a windfall for the University of Queensland — and highlighted a promising model for commercialising Aussie research.